Christopher Pratt, DO
Pain Medicine · Fort Worth, TXNPI 1700851292
Payments from drug & device makers
Across 756 payments — averaging $45.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MML US, Inc.$10K
- Medtronic$4K
- Abbott$4K
- Boston Scientific$2K
- Nevro Corp.$2K
- Nalu Medical, Inc.$2K
- plus $10K from 46 others
What the payments were for
- Speaking & faculty fees$4,40013%
- Travel & lodging$3,0189%
- Food & beverage$26,63678%
- Education$850%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ReActiv8$7,679
- INTELLIS ADAPTIVESTIM$2,881
- Nalu Neurostimulation System$1,221
- Senza Spinal Cord Stimulation System$1,076
- SPRINT PNS System$1,065
- Proclaim Family of SCS IPGs$1,045
- PROCLAIM$1,016
- Prolate$665
- Intracept$596
- Omnia$537
- Superion ISS$531
- WaveWriter Alpha Prime 16$494
- PAINTEQ$307
- Proclaim IPG$285
- Prospera$250
- Lucemyra/Lofexidine$248
- AIMOVIG$231
- INCEPTIV$229
- GENERAL - THERAPIES$168
- Nalocet$166
How this compares
$34,139 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,616 | $43,265 |
| Hysingla ErHydrocodone Bitartrate | 24 | $12,226 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 279 | $7,558 |
| Buprenorphine | 30 | $7,270 |
| Morphine Sulfate ErMorphine Sulfate | 126 | $3,440 |
| Fentanyl | 23 | $2,567 |
| Pregabalin | 64 | $1,759 |
| Tramadol Hcl ErTramadol Hcl | 21 | $1,273 |
| Oxycodone Hcl | 82 | $1,095 |
| Gabapentin | 94 | $1,004 |
| Tramadol Hcl | 69 | $552 |
| Celecoxib | 15 | $517 |
| Methocarbamol | 43 | $318 |
| Cyclobenzaprine Hcl | 22 | $235 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $174 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fort Worth
- Ashley Bailey-ClassenFort Worth$244K
- Israel PenaFort Worth$24K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.